30 September 2020: Articles
Homomorphic Adenocarcinoma Metastases to the Liver: A Report of 2 Cases
Challenging differential diagnosis, Diagnostic / therapeutic accidents, Unexpected drug reaction , Rare disease
Simcha Weissman1ABDEFG*, Tej I. Mehta2EF, Alex Zhornitskiy3DE, Rani Berry3EF, Melanie Burgos1DE, Payman Fathizadeh4BD, James H. Tabibian5ABDEFDOI: 10.12659/AJCR.922932
Am J Case Rep 2020; 21:e922932
Abstract
BACKGROUND: Distinguishing between primary and metastatic malignancy can be challenging despite advances in diagnostic imaging, tissue sampling techniques, and immunohistochemistry.
CASE REPORT: Herein, we describe 2 cases of obscure liver lesions which were ultimately determined to be malignant and from metastatic disease. In both cases, the liver metastases were uniquely “homomorphic,” i.e., radiographically resembling the primary tumor source (in the first case a dilated tubular appearance akin to the hepatopancreatic ampulla and in the second case a haustrated bowel appearance akin to the colon).
CONCLUSIONS: These cases illustrate the recently reported concept of tumor homomorphism as a potential diagnostic pearl to facilitate timely diagnosis of malignant-appearing liver lesions of obscure etiology and source and thereby guide management accordingly.
Keywords: Ampulla of Vater, Endoscopy, Digestive System, Liver Neoplasms, Neoplasm Metastasis, Adenocarcinoma, Immunohistochemistry
Background
Differentiating between the primary and metastatic source and/or site of a malignancy can be challenging despite advances in imaging, tissue sampling techniques, histopathology, and immunohistochemistry [1]. This can be particularly true in gastrointestinal and hepatobiliary malignancies due to various anatomical factors [2]. Nonetheless, identifying the underlying primary disease is crucial for guiding appropriate therapeutic or palliative treatment [2]. Herein, we describe 2 cases in which liver lesions of unclear etiology were acutely encountered. In both cases, the lesions were ultimately determined to be from metastatic adenocarcinoma (ampullary in the first and colonic in the second) and were curiously “homomorphic” in appearance, i.e., their radiographic appearance resembled a dilated tubular structure akin to the ampulla and a haustrated bowel akin to the colon, respectively. “Homomorphism” is a relatively new and perhaps novel term within the literature, and the finding of tumor homomorphism can be considered as a diagnostic pearl in determining an otherwise unsuspected or uncertain primary source of metastatic disease [1,2].
Case Reports
CASE 1:
A 51-year-old man who initially presented to an outside Emergency Department with dyspnea and right upper-quadrant abdominal pain was found to have a large (6-cm) liver mass on abdominal ultrasound. Liver biopsy showed features of metastatic signet-ring cell carcinoma of unknown primary source despite additional imaging of the chest and pelvis. The patient was given 1 cycle of chemotherapy during that hospitalization (on the premise of it being a malignancy of unknown primary) and was referred to our medical center for further evaluation and treatment. Interval computed tomography (CT) of the abdomen showed a large, cystic/capacious lesion in the liver, anatomically resembling an ampulla, as well as distal bile duct thickening and periampullary fullness with associated duodenal stenosis (Figure 1). Due to worsening jaundice and bile duct dilation, he was referred for palliative biliary decompression. As the source of the primary malignancy remained unclear, he was sent for an endoscopy. Upon endoscopy, a friable, malignant appearing, obstructive mass was seen in the region of the major duodenal papilla (Figure 2). The mass was biopsied, and a Hanaro (Olympus America, Center Valley, PA) 22×90 mm duodenal self-expanding metallic stent (SEMS) was placed (this was the first FDA-approved application of this stent in the United States) (Figure 3). Biopsies of the papillary mass showed tumor cells with signet-ring features and a mucinous background (Figure 4), while consistent with signet-ring adenocarcinoma, a finding that likely would not have been made (at least in the time frame that it was) had the diagnostic clue of the “homomorphic” appearance of the liver lesion on CT (a finding that was not identified in the radiology report) not been recognized by the clinical team.
CASE 2:
A 46-year-old man presented to our Emergency Department for the evaluation of nausea, vomiting, constipation, and 5 months of progressive generalized abdominal pain, accompanied by a 20-pound weight loss. On physical examination, his abdomen was distended, diffusely tender without rebound, and with a suggestion of hepatomegaly. A computed tomography (CT) scan of the abdomen and pelvis was significant for annular thickening of the rectosigmoid junction and numerous hypodense liver lesions of unclear etiology, seemingly replacing the majority of the hepatic parenchyma, worrisome for multifocal primary liver cancer versus diffuse hepatic metastases (Figure 5). Results of laboratory investigations showed leukocytosis (16 000/mm3), anemia (11.5 g/dL), normal platelet count, international normalized ratio of 1.5, total bilirubin of 20.1 mg/dL, and alkaline phosphatase of 494 IU/L. Percutaneous liver biopsy revealed infiltrative malignant glands positive for CK20 and CDX2 and negative for CK7, consistent with intestinal-type adenocarcinoma, suggestive of colorectal primary. Notably, the large intestine was not examined previously due to physical constraints at that time. On further review of CT images, the liver lesions were reminiscent of the colon, i.e., with capacious-appearing morphology and haustra-like septations (Figure 6). Therefore, based on these findings (the haustrated bowel-like appearance on CT), the patient was promptly referred for colonoscopy. This revealed a firm, malignant-appearing mass lesion at the rectosigmoid junction; the mass could not be traversed with the colonoscope or diagnostic gastroscope. Based on the overall findings, a 25×90 mm WallFlex (Boston Scientific, Natick, MA) SEMS was placed across the stricture for palliation of the obstruction. The patient was discharged the following day with outpatient oncology follow-up to arrange palliative therapy.
Discussion
The liver is a common site of tumor metastasis, which in some cases can be of unclear primary source. Indeed, more than half of all metastatic adenocarcinomas are of unknown origin at the time of initial clinical evaluation [3]. While numerous diagnostic modalities exist that can help detect the primary malignancy, they are usually costly and relatively time-consuming, and may be inconclusive [3]. Consequently, the search for an unknown primary tumor is a common clinical problem [4]. One diagnostic approach is via additional tissue staining, e.g., using CK-20 and CK-7, which can help elucidate a certain subset of primary tumors [4]. However, even with this, a primary tumor source can be elusive. Hence, as recently reported [1,2] and as illustrated herein, the presence of tumor homomorphism may allow a clinician to visually link a metastatic lesion to its primary source, thereby providing a unique diagnostic clue.
Despite the fact that only 3 other cases of “homomorphic” metastases have been reported, we believe this finding is generally overlooked/unrecognized, and thus may in fact be more common, although its pathobiology and prognostic significance remain largely unknown [1,2]. As seen in our series of cases, tumor homomorphism, when recognized, may help expedite targeted diagnostic testing and subsequently provide more timely and cost-effective care.
Conclusions
This case series shows the importance of considering the concept of radiographic homomorphism in correlating a metastatic tumor with its potential primary source. Tumor homomorphism can aid in facilitating earlier real-time diagnosis, which can have both economic and prognostic implications.
Figures
References:
1.. Weissman S, Mehta TI, Zhornitskiy A, “Homomorphic” tumor metastases as an endodiagnostic clue: A case series of renal-cell carcinoma metastatic to the stomach: Gastrointest Tumors, 2019; 6; 147-52
2.. Weissman S, Mehta TI, Berry R, Tabibian JH, A path less traveled: Metastatic esophageal carcinoma from a primary ovarian malignancy: J Gastrointest Cancer, 2019; 51(1); 329-31
3.. Hainsworth JD, Greco FA, Treatment of patients with cancer of unknown primary site: N Engl J Med, 1993; 329; 257-63
4.. Tot T, Adenocarcinomas metastatic to the liver: The value of cytokeratins 20 and 7 in the search for unknown primary tumors: Cancer, 1999; 85(1); 171-77
Figures
In Press
28 Sep 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.940411
28 Sep 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939789
27 Sep 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.941414
26 Sep 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.940966
Most Viewed Current Articles
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
07 Dec 2021 : Case report
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250